WHITEPAPER
AUTHOR:

Linda Pullan, PhD
Pullan Consulting

Jeff Bockman, PhD
Vice President, Defined Health
Jeff leads the Oncology and Virology Practices at Defined Health. He received a BA from University of California at San Diego, a PhD in Medical Microbiology from the University of California at Berkeley, and an MA in English/Creative Writing from New York University. Learn More

Axel Hoos, MD, PhD
Vice President, Oncology R&D and Head of Immuno-Oncology at GlaxoSmithKline Pharmaceuticals (GSK)

Ferran Prat, PhD
VP of Strategic Industry Ventures, MD Anderson
Ferran helps the faculty and researchers at MD Anderson develop collaborative opportunities with pharmaceutical, biotech, diagnostics, imaging, laboratory medicine and other industry partners. Learn More

Nathan Sanburn, MS
East Region Director, Medical Oncology, Eli Lilly & Company
Nathan Sanburn currently serves as the Strategy and Business Development Director for the Oncology Business Unit at Lilly. He is a molecular biologist by training, with over 19 years of experience across R&D, clinical trials, and business transactions.
SPONSORED BY



